Bausch & Lomb, Inc.: FDA filings under this applicant name
FDA lists 138 510(k) clearances under 9 spellings of the applicant name “Bausch & Lomb, Inc.” (first 1977, latest 2026), plus 32 PMA decisions, across 45 product codes in 7 review panels. Median 510(k) review time under this name: 75 days. Since 2017 the median was 90 days, against 97 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Bausch + Lomb, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 5 | 207 |
| 2013 | 6 | 124 |
| 2014 | 4 | 118 |
| 2015 | 2 | 40 |
| 2016 | 3 | 147 |
| 2017 | 7 | 59 |
| 2018 | 3 | 51 |
| 2019 | 2 | 78 |
| 2020 | 2 | 154 |
| 2021 | 3 | 177 |
| 2022 | 1 | 106 |
| 2023 | 2 | 298 |
| 2024 | 3 | 186 |
| 2025 | 0 | — |
| 2026 | 3 | 56 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Bausch & Lomb, Inc. took a median 90 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 97 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| LPL | Lenses, Soft Contact, Daily Wear | 21 | 21 |
| LPN | Accessories, Soft Lens Products | 20 | 20 |
| HQL | Intraocular Lens | 16 | 0 |
| HQC | Unit, Phacofragmentation | 15 | 15 |
| MSS | Folders And Injectors, Intraocular Lens (Iol) | 12 | 12 |
| HQD | Lens, Contact (Other Material) - Daily | 8 | 8 |
| LPM | Lenses, Soft Contact, Extended Wear | 7 | 0 |
| JJQ | Colorimeter, Photometer, Spectrophotometer For Clinical Use | 6 | 6 |
| HPX | Lens, Contact (Polymethylmethacrylate) | 5 | 5 |
| MRC | Products, Contact Lens Care, Rigid Gas Permeable | 5 | 5 |
Plus 35 more product codes.
Review panels
- Ophthalmic (153)
- Clinical Chemistry (6)
- Ear, Nose and Throat (4)
- Dental (3)
- General Hospital (1)
- Pathology (1)
- General and Plastic Surgery (1)
Most recent Bausch & Lomb, Inc. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K262941 | Bausch + Lomb Multifocal for Astigmatism (kalifilcon A) One-Day Soft (hydrophilic) Contact Lens | LPL | 2026-10-16 | 56 |
| K261264 | Stellaris Elite vision enhancement system; Posterior and Combined Procedure Pack(s): 23 ga. Posterior Elite Pack (SE5423); 23 ga. Bi-Blade Vitreous Cutter Posterior Stellaris Elite Pack (SE5423B); 25 ga. Posterior Elite Pack (SE5425); 25 ga. Bi-Blade Vitreous Cutter Posterior Stellaris Elite Pack (SE5425B); 27 ga. Bi-Blade Vitreous Cutter Posterior Stellaris Elite Pack (SE5427B); 23 ga. Bi-Blade+ Vitreous Cutter Posterior Stellaris Elite Pack (SE5423BB+); 25 ga. Bi-Blade+ | HQC | 2026-05-15 | 29 |
| K252052 | Stellaris Elite vision enhancement system (BL11145, BL14455, BL15455, SE14565, SE15565, SE14565E, SE15565E) | HQC | 2026-03-25 | 267 |
| K242389 | EyeGility Inserter for Preloaded enVista IOLs | MSS | 2024-10-10 | 59 |
| K240169 | Stellaris Elite vision enhancement system (BL11145, BL14455, BL15455) | HQC | 2024-07-26 | 186 |
| K232084 | Stellaris Elite vision enhancement system | HQC | 2024-02-26 | 228 |
| K230954 | Samfilcon B Custom Contact Lens | LPL | 2023-11-17 | 227 |
| K220613 | Bausch + Lomb (kalifilcon A) Soft (hydrophilic) Contact Lens, Bausch + Lomb (kalifilcon A) Soft (hydrophilic) Contact Lens for Astigmatism, and, Bausch + Lomb (kalifilcon A) Soft (hydrophilic) Contact Lens for Presbyopia | LPL | 2023-03-08 | 370 |
| K222541 | Bausch + Lomb Preservative Free Lubricating and Rewetting Drops | LPN | 2022-12-06 | 106 |
| K211786 | Independent Corneal Viewing Chamber (IVC-21) | LYX | 2021-12-03 | 177 |
128 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P240005 | PMA | enVista Envy hydrophobic acrylic intraocular lens (IOL), enVista Envy toric hydrophobic acrylic intraocular lens (IOL) | 2024-10-10 |
| P170035 | PMA | Bausch + Lomb Ultra (samfilcon A) Contact Lenses | 2018-04-30 |
| P080021 | PMA | XACT FOLDABLE HYDROPHOBIC ACRYLIC ULTRAVIOLET LIGHT-ABSORBING POSTERIOR CHAMBER INTRAOCULAR LENS (IOL) | 2009-02-02 |
| P060022 | PMA | AKREOS POSTERIOR CHAMBER INTRAOCULAR LENS,MODEL ADAPT | 2008-09-05 |
| P010062 | PMA | EUCLID SYSTEMS ORTHOKERATOLOGY (OPRIFOCON A) CONTACT LENS FOR OVERNIGHT WEAR | 2004-06-07 |
Recalls
82 product recalls in 28 recall events; 0 initiated in the last five years. Most recent: 2018-08-08.
19 product recalls in 13 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 3 initiated in the last five years. Most often: Bausch & Lomb Surgical, Inc. (9), Anika Therapeutics (4), Alden Optical (2).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Bausch & Lomb, Inc. is the lead sponsor of 96 device studies on ClinicalTrials.gov (3 active or recruiting). Most recent:
- NCT07377474: A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism (Not yet recruiting, started 2026-04)
- NCT06785194: Revive Toric RWE Study (Withdrawn, started 2026-03)
- NCT06618547: Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive Keratectomy (Not yet recruiting, started 2025-11)
- NCT06594185: A Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract Extraction (Completed, started 2024-08-29)
- NCT06479148: Clinical Evaluation of the Performance of the enVista® Aspire™ (EA) Lens (Terminated, started 2024-08-15)
Parent company SEC filings
Bausch & Lomb Corp (BLCO): EDGAR filings, CIK 1860742. Caduvo groups Bausch & Lomb, Inc. under Bausch + Lomb; the parent's SEC registrant is entered by hand for the group, not matched by name.
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Bausch & Lomb, Inc. (a text match, not an official crosswalk):
- A4220 — Refill kit for implantable infusion pump (via MRH)
- E0786 — Implantable programmable infusion pump, replacement (excludes implantable intraspinal catheter) (via MRH)
FDA spellings included
FDA records this applicant under 9 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Bausch & Lomb, Inc. (114)
- Bausch & Lomb, Incorporated (24)
- Bausch & Lomb (18)
- Bausch + Lomb, Incorporated (4)
- Bausch and Lomb, Incorporated (3)
- Bausch and Lomb (2)
- Bausch and Lomb, Inc., (2)
- Bausch+Lomb (2)
- Bausch + Lomb, Inc. (1)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Bausch & Lomb Pharmaceutical, Inc. (6 510(k)s)
- Bausch & Lomb Healthcare and Optics Worldwide (1 510(k)s)
- Bausch Health Americas Incorporated (1 510(k)s)
- Bausch + Lomb Ireland Limited (0 510(k)s)
- Bausch & Lomb Surgical, Inc. (0 510(k)s)
- Bausch Health (0 510(k)s)
- Bausch Health Companies, Inc. (0 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Bausch & Lomb, Inc.?
FDA lists 138 510(k) clearances under 9 spellings of the applicant name “Bausch & Lomb, Inc.” (first 1977, latest 2026), plus 32 PMA decisions, across 45 product codes in 7 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Bausch & Lomb, Inc.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Bausch & Lomb, Inc. is 75 days. Since 2017: 90 days, versus 97 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Bausch & Lomb, Inc.?
The most frequent FDA product codes under this applicant name are LPL (Lenses, Soft Contact, Daily Wear, 21); LPN (Accessories, Soft Lens Products, 20); HQL (Intraocular Lens, 16).
Next steps
- See all 138 Bausch & Lomb, Inc. clearances with predicates and recalls
- Run predicate analysis for product code LPL, Bausch & Lomb, Inc.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.